Invitris Analysis: $0.1M Raised

What is Invitris?

Invitris specializes in cell-free protein expression technology, enabling the rapid development of synthetic proteins. Their unique approach combines protein engineering and biomanufacturing to achieve high yields and purity. This technology supports various applications, including human therapeutics and industrial uses, transforming protein production processes.

Product Features & Capabilities

• Cell-free protein expression technology for synthetic proteins
• Prokaryotic and eukaryotic expression systems
• Antibody engineering for complex diseases
• Phage development for antibacterial solutions
• Rapid prototyping and optimization of proteins.

How much Invitris raised